MULTISUBSTITUTED AROMATIC COMPOUNDS AS SERINE PROTEASE INHIBITORS

(19)

(11)

EP 3 421 036 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	30.12.2020 Bulletin 2020/53

(45)	Mention of the grant of the patent:
	18.11.2020 Bulletin 2020/47

(21)	Application number: 18189634.1

(22)	Date of filing: 17.03.2014

(51)

International Patent Classification (IPC):

C07D 405/14^(2006.01)
C07D 401/04^(2006.01)
C07D 409/14^(2006.01)
A61K 31/4427^(2006.01)
A61P 27/02^(2006.01)

C07D 231/38^(2006.01)
C07D 403/04^(2006.01)
A61K 31/4439^(2006.01)
A61K 31/4178^(2006.01)

(54)	MULTISUBSTITUTED AROMATIC COMPOUNDS AS SERINE PROTEASE INHIBITORS MULTISUBSTITUIERTE AROMATISCHE VERBINDUNGEN ALS SERINPROTEASEINHIBITOREN COMPOSÉS AROMATIQUES MULTISUBSTITUÉS EN TANT QU'INHIBITEURS DE SÉRINE PROTÉASE

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

15.03.2013 US 201361789358 P

(43)	Date of publication of application:
	02.01.2019 Bulletin 2019/01

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	14764515.4 / 2968297

(73)	Proprietor: Verseon International Corporation
	Dover, DE 19901 (US)

(72)	Inventors:
	SHORT, Kevin, Michael Fremont, California 94538 (US) PHAM, Son, Minh Fremont, California 94538 (US) WILLIAMS, David, Charles Fremont, California 94538 (US) KITA, David, Ben Fremont, California 94538 (US)

(74)	Representative: HGF
	1 City Walk Leeds LS11 9DX Leeds LS11 9DX (GB)

(56)

References cited: :

WO-A1-2016/044662

WO-A2-2011/126903

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).